{
    "clinical_study": {
        "@rank": "13480", 
        "brief_summary": {
            "textblock": "To determine the bioavailability, pharmacokinetics, and short-term safety and tolerance of\n      nevirapine in HIV-1 infected pregnant women and their newborns when nevirapine is given to\n      the mother during active labor, and when their neonates are dosed during the first week of\n      life. To determine the short-term safety profile of mothers receiving zidovudine (AZT) who\n      received nevirapine during active labor, and their neonates who received no dose, a single\n      dose, or multiple doses of nevirapine and who are receiving AZT during the first 6 weeks of\n      life.\n\n      Treatment of HIV-1 infected pregnant women during active labor may result in therapeutic\n      levels of nevirapine in the neonate at the time of exposure to HIV-1 during parturition,\n      decreasing the neonate's risk of infection."
        }, 
        "brief_title": "A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers", 
        "completion_date": {
            "#text": "September 1998", 
            "@type": "Actual"
        }, 
        "condition": [
            "HIV Infections", 
            "Pregnancy"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "Treatment of HIV-1 infected pregnant women during active labor may result in therapeutic\n      levels of nevirapine in the neonate at the time of exposure to HIV-1 during parturition,\n      decreasing the neonate's risk of infection.\n\n      Pregnant women in active labor receive single doses of oral nevirapine. The neonates of the\n      first 4-6 (PER AMENDMENT 8/27/96, was 4) mothers receive no drug, while the neonates of the\n      second 4-6 (PER AMENDMENT 8/27/96, was 4) patient cohort receive a single dose of\n      nevirapine. If neonatal antiviral levels of nevirapine are not sustained for 7 days after\n      the single dose, a third cohort of 4-6 (PER AMENDMENT 8/27/96, was 4) pregnant women will\n      receive a single dose of nevirapine and their neonates will receive multiple doses of\n      nevirapine to maintain an antiviral effect for 7 days."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Concurrent Medication:\n\n        Allowed:\n\n          -  AZT (mothers and neonates).\n\n          -  Oral asthma inhalers (mothers).\n\n        Concurrent Treatment:\n\n        Allowed:\n\n          -  Phototherapy (neonates).\n\n        MOTHERS must have:\n\n          -  HIV infection.\n\n          -  Estimated gestational age >= 34 weeks.\n\n          -  No active opportunistic infection at study entry.\n\n        PER AMENDMENT 8/27/96:\n\n          -  A pre-enrollment plasma HIV-1 RNA level greater than 10,000 copies/ml.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        MOTHERS with the following symptoms or conditions are excluded:\n\n          -  Intrauterine growth retardation.\n\n          -  Fetal anomaly incompatible with life as determined by pre-entry ultrasound.\n\n          -  Participation during current pregnancy in any other therapeutic or vaccine perinatal\n             trial.\n\n          -  Known hypersensitivity to any benzodiazepine.\n\n          -  Serious bacterial infection.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Any antiretroviral other than AZT.\n\n          -  Corticosteroids (other than oral asthma inhalers).\n\n          -  Anticoagulants.\n\n          -  Any clavulanic acid-containing formulation (e.g., Augmentin, Timentin).\n\n          -  Benzodiazepines other than study drug.\n\n          -  Phenobarbital.\n\n          -  Barbiturates.\n\n          -  Antacids.\n\n          -  Magnesium sulfate.\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Prior nevirapine.\n\n        Current use of illicit substances and/or active chronic alcohol use."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "13 Years"
        }, 
        "enrollment": "49", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000808", 
            "org_study_id": "ACTG 250", 
            "secondary_id": "11227"
        }, 
        "intervention": {
            "intervention_name": "Nevirapine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Nevirapine"
        }, 
        "keyword": [
            "Pregnancy", 
            "Pregnancy Complications, Infectious", 
            "Acquired Immunodeficiency Syndrome", 
            "AIDS-Related Complex", 
            "Nevirapine"
        ], 
        "lastchanged_date": "March 30, 2012", 
        "link": {
            "description": "Click here for more information about Nevirapine", 
            "url": "http://www.aidsinfo.nih.gov/DrugsNew/DrugDetailNT.aspx?MenuItem=Drugs&Search=On&int_id=116"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "La Jolla", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "920930672"
                    }, 
                    "name": "UCSD Med Ctr / Pediatrics / Clinical Sciences"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "900951752"
                    }, 
                    "name": "UCLA Med Ctr / Pediatric"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "905022004"
                    }, 
                    "name": "Harbor - UCLA Med Ctr / UCLA School of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90033"
                    }, 
                    "name": "Los Angeles County - USC Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94110"
                    }, 
                    "name": "San Francisco Gen Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "941430105"
                    }, 
                    "name": "UCSF / Moffitt Hosp - Pediatric"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Farmington", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06032"
                    }, 
                    "name": "Univ of Connecticut / Farmington"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hartford", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06106"
                    }, 
                    "name": "Connecticut Children's Med Ctr - Pediatric"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "606143394"
                    }, 
                    "name": "Chicago Children's Memorial Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "606371470"
                    }, 
                    "name": "Univ of Chicago Children's Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "021155724"
                    }, 
                    "name": "Children's Hosp of Boston"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02118"
                    }, 
                    "name": "Boston City Hosp / Pediatrics"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Worcester", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "016550001"
                    }, 
                    "name": "Univ of Massachusetts Med School"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newark", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "071032714"
                    }, 
                    "name": "Univ of Medicine & Dentistry of New Jersey / Univ Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10029"
                    }, 
                    "name": "Mount Sinai Med Ctr / Pediatrics"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Juan", 
                        "country": "Puerto Rico", 
                        "zip": "009367344"
                    }, 
                    "name": "San Juan City Hosp"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Puerto Rico"
            ]
        }, 
        "official_title": "A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers", 
        "overall_official": [
            {
                "last_name": "Sullivan JL", 
                "role": "Study Chair"
            }, 
            {
                "last_name": "Sperling R", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 1", 
        "reference": [
            {
                "PMID": "11364450", 
                "citation": "Vazquez E. Two bucks a baby. Posit Aware. 1997 Mar-Apr;8(2):15. No abstract available."
            }, 
            {
                "PMID": "11362587", 
                "citation": "Benson M, Shannon M. Nevirapine: ethical dilemmas and care for HIV-infected mothers. Focus. 1995 Jun;10(7):5-6. No abstract available."
            }, 
            {
                "citation": "McKinney RE Jr. Ongoing and future trials of antiretroviral therapy in the pediatric AIDS clinical trials group (PACTG). Conf Retroviruses Opportunistic Infect. 1996 Jan 28-Feb 1;3rd:173"
            }, 
            {
                "citation": "Mirochnick M, Sullivan J, Cort S, Mcnamara J, Fenton T, Sperling R. Safety and pharmacokinetics (pk) of nevirapine (NVP) in HIV-I infected pregnant women and their newborns. ACTG Protocol 250 Team. American Pediatric Association and Society for Pediatric Research annual meeting; 1996 May 6-10; Washington, D.C. Pediatr AIDS HIV Infect. 1996 Aug;7(4):280 (unnumbered abstract)"
            }, 
            {
                "PMID": "9697716", 
                "citation": "Mirochnick M, Fenton T, Gagnier P, Pav J, Gwynne M, Siminski S, Sperling RS, Beckerman K, Jimenez E, Yogev R, Spector SA, Sullivan JL. Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team. J Infect Dis. 1998 Aug;178(2):368-74."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000808"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "National Institute of Allergy and Infectious Diseases (NIAID)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of Allergy and Infectious Diseases (NIAID)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Endpoint Classification: Pharmacokinetics Study, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2012"
    }, 
    "geocoordinates": {
        "Boston City Hosp / Pediatrics": "42.358 -71.06", 
        "Chicago Children's Memorial Hosp": "41.878 -87.63", 
        "Children's Hosp of Boston": "42.358 -71.06", 
        "Connecticut Children's Med Ctr - Pediatric": "41.764 -72.685", 
        "Harbor - UCLA Med Ctr / UCLA School of Medicine": "34.052 -118.244", 
        "Los Angeles County - USC Med Ctr": "34.052 -118.244", 
        "Mount Sinai Med Ctr / Pediatrics": "40.714 -74.006", 
        "San Francisco Gen Hosp": "37.775 -122.419", 
        "San Juan City Hosp": "18.466 -66.106", 
        "UCLA Med Ctr / Pediatric": "34.052 -118.244", 
        "UCSD Med Ctr / Pediatrics / Clinical Sciences": "32.839 -117.277", 
        "UCSF / Moffitt Hosp - Pediatric": "37.775 -122.419", 
        "Univ of Chicago Children's Hosp": "41.878 -87.63", 
        "Univ of Connecticut / Farmington": "41.728 -72.84", 
        "Univ of Massachusetts Med School": "42.263 -71.802", 
        "Univ of Medicine & Dentistry of New Jersey / Univ Hosp": "40.736 -74.172"
    }
}